홈 / 슈퍼인베스터 / 보포스트 그룹

보포스트 그룹

BAUPOST · CIK 0001061768 · 2019-06-30 기준 · 원본 신고 1건 (최근 2019-08-13) · EDGAR 원문

2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 CSV JSON
평가액
$10.73B
보유 종목
30
상위 10 비중
72.3%

보유 종목

30종목
종목 보유수량 평가액 ▲ 신고가 현재가 ±신고 52주 비중
PARATEK PHARMACEUTICALS INC
699374302 · 2014-12-31부터 · -88.9%
2,394,498 $9.554M $3.99 - - - 0.1%
GOSSAMER BIO INC
38341P102 · 2019-03-31부터 · +4.4%
1,267,171 $27.25M $21.51 - - - 0.3%
SINCLAIR BROADCAST GROUP INC
829226109 · 2018-06-30부터 · +66.8%
549,423 $29.47M $53.63 - - - 0.3%
TRILOGY METALS INC NEW
TMQ · 89621C105 · 2016-09-30부터 · +432.4%
13,641,368 $39.77M $2.92 $1.94 -33.5% $1.94 – $6.89 0.4%
VERITIV CORP
923454102 · 2014-09-30부터 · -61.2%
3,564,439 $69.22M $19.42 - - - 0.6%
XPO INC
XPO · 983793100 · 2019-06-30부터 · 0.0%
1,500,000 $86.72M $57.81 $192.81 +233.5% $125.64 – $228.37 0.8%
TRANSLATE BIO INC
89374L104 · 2018-06-30부터 · -2.2%
8,844,239 $109.4M $12.37 - - - 1.0%
AKEBIA THERAPEUTICS INC
AKBA · 00972D105 · 2018-12-31부터 · -12.5%
24,471,453 $118.4M $4.84 $0.47 -90.2% $0.40 – $1.76 1.1%
ATARA BIOTHERAPEUTICS INC
046513107 · 2014-12-31부터 · -15.1%
7,000,000 $140.8M $20.11 - - - 1.3%
NEXSTAR MEDIA GROUP INC
NXST · 65336K103 · 2018-12-31부터 · +28.4%
1,397,755 $141.2M $101.00 $207.94 +105.9% $154.70 – $253.64 1.3%
THERAVANCE BIOPHARMA INC
G8807B106 · 2014-06-30부터 · -48.8%
9,309,168 $152M $16.33 - - - 1.4%
ANTERO RESOURCES CORP
AR · 03674X106 · 2014-09-30부터 · -89.9%
28,587,791 $158.1M $5.53 $38.74 +600.5% $31.38 – $45.15 1.5%
TAKEDA PHARMACEUTICAL CO LTD
TAK · 874060205 · 2019-03-31부터 · -13.1%
9,438,003 $167.1M $17.70 $21.43 +21.1% $14.06 – $21.43 1.6%
CENCORA INC
COR · 03073E105 · 2016-12-31부터 · +9.0%
2,214,192 $188.8M $85.26 $359.03 +321.1% $252.74 – $374.75 1.8%
LIBERTY GLOBAL PLC
G5480U104 · 2018-09-30부터 · -6.7%
7,440,705 $200.8M $26.99 - - - 1.9%
Fox Corp.
FOX · 35137L204 · 2019-03-31부터 · +1.8%
5,680,307 $207.5M $36.53 $61.11 +67.3% $44.39 – $67.76 1.9%
UNIVAR INC
91336L107 · 2018-09-30부터 · -28.1%
9,500,000 $209.4M $22.04 - - - 2.0%
COLONY CAP INC NEW
19626G108 · 2018-06-30부터 · -19.9%
49,687,370 $248.4M $5.00 - - - 2.3%
SYNCHRONY FINANCIAL
SYF · 87165B103 · 2016-09-30부터 · +23.8%
9,260,557 $321.1M $34.67 $72.25 +108.4% $63.78 – $88.47 3.0%
MCKESSON CORP
MCK · 58155Q103 · 2016-12-31부터 · -4.3%
2,595,011 $348.7M $134.39 $1,102.81 +720.6% $725.17 – $1,102.81 3.3%
CBS Corp.
124857202 · 2018-12-31부터 · +14.1%
10,000,000 $499M $49.90 - - - 4.7%
PG&E CORP
PCG · 69331C108 · 2018-03-31부터 · -47.8%
24,500,000 $561.5M $22.92 $13.25 -42.2% $11.95 – $19.11 5.2%
QORVO INC
74736K101 · 2017-03-31부터 · -2.8%
8,681,181 $578.3M $66.61 - - - 5.4%
BRISTOL-MYERS SQUIBB CO
BMY · 110122108 · 2019-03-31부터 · -4.9%
13,000,000 $589.6M $45.35 $63.43 +39.9% $45.79 – $68.09 5.5%
ALLERGAN PLC
G0177J108 · 2016-03-31부터 · -37.5%
3,679,549 $616.1M $167.43 - - - 5.7%
CHENIERE ENERGY INC
LNG · 16411R208 · 2014-03-31부터 · +23.7%
10,674,135 $730.6M $68.45 $308.75 +351.1% $188.83 – $330.32 6.8%
EBAY INC
EBAY · 278642103 · 2014-06-30부터 · -21.1%
24,146,000 $953.8M $39.50 $120.92 +206.1% $79.41 – $125.15 8.9%
Fox Corp.
FOXA · 35137L105 · 2019-03-31부터 · -0.2%
27,322,720 $1.001B $36.64 $68.42 +86.7% $48.79 – $76.11 9.3%
VIASAT INC
VSAT · 92552V100 · 2013-06-30부터 · +13.1%
13,732,068 $1.11B $80.82 $67.72 -16.2% $30.35 – $89.81 10.3%
LIBERTY GLOBAL PLC
G5480U120 · 2018-09-30부터 · -5.8%
41,937,674 $1.113B $26.53 - - - 10.4%

32개 신고 항목을 30개 CUSIP으로 합산했습니다. 위임 운용사별로 나뉜 항목은 합산합니다.

13F는 롱 포지션만(롱옵션 포함, 숏·현금 제외)이며 분기말 기준입니다.

그 외 신고 항목

2건
종목 종류 수량·원금 평가액
TESLA INC
88160RAD3
원금 표시(채권·노트) 300,000,000 $295.5M
THERAVANCE BIOPHARMA INC
88339KAA0
원금 표시(채권·노트) 30,000,000 $25.73M

채권·노트(원금 표시)·선호주·예탁증권·값 없는 항목·옵션(콜·풋)은 참고로 싣되 평가액·종목수에는 세지 않습니다 — 주식수 기준·값 0 초과·옵션 제외·선호주 제외(Dataroma 방식). 옵션은 계약 수가 아니라 기초 주식수와 그 평가액으로 적습니다.